Drug Index
ENBREL
Generic: ETANERCEPT
Review priority: STANDARD Marketing status: Prescription
- Route: SUBCUTANEOUS
- Class: General Medications
- Safety profile: routine
- Latest regulatory update: 30 Jan 2026, 12:00 am (UTC)
Structured Monograph
Approval overview ENBREL is listed in Drugs@FDA under application 103795 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient ETANERCEPT Form and strength VIAL; SUBCUTANEOUS - 25MG/VIAL Sponsor IMMUNEX Submission history Latest submission status date: 2026-01-30 00:00:00. Submission type: SUPPL.